Application of Finnish Diabetes Risk Score (FINDRISC) in Detecting Subjects at Risk for Type 2 Diabetes Mellitus: Results from Community Pharmacies in Sulaimani City, Iraq

Khanda Taifwr  Hamasalih; Bushra Hassan Marouf; Przha Majeed Mahmood

doi:10.54133/ajms.v8i1.1746

Authors

Khanda Taifwr Hamasalih Department of Clinical Pharmacy, College of Pharmacy, University of Sulaimani, Kurdistan Region, Iraq https://orcid.org/0009-0000-8688-7690
Bushra Hassan Marouf Department of Pharmacology and Toxicology, College of Pharmacy, University of Sulaimani, Kurdistan Region, Iraq https://orcid.org/0000-0002-7658-9013
Przha Majeed Mahmood Private Community Pharmacy, Sulaimani, Kurdistan Region, Iraq https://orcid.org/0009-0002-4418-190X

DOI:

https://doi.org/10.54133/ajms.v8i1.1746

Keywords:

Community pharmacy, Diabetes risk assessment, FINDRISC

Abstract

Background: The FINDRISC tool was used to screen subjects at risk for type 2 diabetes mellitus (T2DM) with no involvement of laboratory tests. Subjects with undiagnosed diabetes mellitus face a significant risk of developing complications. Thus, early detection is important to minimize its complications. Objective: To evaluate the efficiency of the FINDRISC in screening for undiagnosed T2DM (UT2DM) in Sulaimani community pharmacies. Methods: This cross-sectional study was carried out in four community pharmacies in Sulaimani city, Iraq. A questionnaire that included the FINDRISC variables was utilized in collecting data from 384 participants after giving informed consent. If the FINDRISC was ≥15 points and blood glucose was ≥140mg/dL, the participant was referred to a physician. Results: Approximately half of the participants (48.2%) were under 45 years old, and the majority (63%) of all participants were female. Based on the score definition of FINDRISC, the risk of T2DM was found to be high in 23.4%, moderate in 23.4%, and low in 18.5% of the participants. Additionally, 44.3% had a body mass index (BMI) between 25 and 30kg/m², while 30.7% had >30 kg/m². A waist circumference of <94cm was found only in 6% of males, and just 3.1% of females had a waist circumference of <80cm. Age, family history, gender, daily activity, and BMI were related to the risk of developing diabetes mellitus. Conclusions: The Finnish Diabetes Risk Score was found to be a helpful tool in determining the risk of T2DM among the study sample.

Downloads

Download data is not yet available.

References

Kalan Farmanfarma KH, Ansari-Moghaddam A, Zareban I, Adineh HA. Prevalence of type 2 diabetes in Middle East: Systematic review& meta-analysis. Prim Care Diabetes. 2020;14(4):297-304. doi: 10.1016/j.pcd.2020.01.003. DOI: https://doi.org/10.1016/j.pcd.2020.01.003

Mansour AA, Al-Maliky AA, Kasem B, Jabar A, Khalid AM. Prevalence of diagnosed and undiagnosed diabetes mellitus in adults aged 19 years and older in Basrah, Iraq. Diabetes Metab Syndr Obes Targets Ther. 2014:139. doi: 10.2147/DMSO.S59652. DOI: https://doi.org/10.2147/DMSO.S59652

Ali A, Al Lami F. Prevalence and determinants of microalbuminurea among type 2 diabetes mellitus patients, Baghdad, Iraq, 2013. Saudi J Kidney Dis Transplant. 2016;27(2):348. doi: 10.4103/1319-2442.178561. DOI: https://doi.org/10.4103/1319-2442.178561

Musafer KNJ, Rava M, Chobok AS, Shamsuddin S, Al-Mousawi MRR, Hayup F. A meta-analysis and review on genetic mapping of type 2 diabetes mellitus in Iraq. Egypt J Med Hum Genet. 2023;24(1):66. doi: 10.1186/s43042-023-00448-4. DOI: https://doi.org/10.1186/s43042-023-00448-4

Abu-Farha M, Tuomilehto J, Abubaker J. Editorial: Diabetes in the Middle East. Front Endocrinol. 2021;12:638653. doi: 10.3389/fendo.2021.638653. DOI: https://doi.org/10.3389/fendo.2021.638653

Meo SA, Sheikh SA, Sattar K, Akram A, Hassan A, Meo AS, et al. Prevalence of type 2 diabetes mellitus among men in the middle east: A retrospective study. Am J Mens Health. 2019;13(3):1557988319848577. doi: 10.1177/1557988319848577. DOI: https://doi.org/10.1177/1557988319848577

Soriguer F, Goday A, Bosch-Comas A, Bordiú E, Calle-Pascual A, Carmena R, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia. 2012;55(1):88-93. doi: 10.1007/s00125-011-2336-9. DOI: https://doi.org/10.1007/s00125-011-2336-9

Uusitupa M, Khan TA, Viguiliouk E, Kahleova H, Rivellese AA, Hermansen K, et al. Prevention of type 2 diabetes by lifestyle changes: A systematic review and meta-analysis. Nutrients. 2019;11(11):2611. doi: 10.3390/nu11112611. DOI: https://doi.org/10.3390/nu11112611

Davidson JA. The increasing role of primary care physicians in caring for patients with type 2 diabetes mellitus. Mayo Clin Proc. 2010;85(12):S3-S4. doi: 10.4065/mcp.2010.0466. DOI: https://doi.org/10.4065/mcp.2010.0466

Chen S, Qian D, Burström B. Shifting the care of type 2 diabetes mellitus from hospital to primary health care institutions through an educational intervention for health care professionals: An example from rural China. Int J Environ Res Public Health. 2020;17(6):2076. doi: 10.3390/ijerph17062076. DOI: https://doi.org/10.3390/ijerph17062076

American Diabetes Association. 5. Prevention or delay of type 2 diabetes. Diabetes Care. 2017;40(Supplement_1):S44-S47. doi: 10.2337/dc17-S008. DOI: https://doi.org/10.2337/dc17-S008

Buijsse B, Simmons RK, Griffin SJ, Schulze MB. Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev. 2011;33(1):46-62. doi: 10.1093/epirev/mxq019. DOI: https://doi.org/10.1093/epirev/mxq019

Correr CJ, Coura-Vital W, Frade JCQP, Nascimento RCRM, Nascimento LG, Pinheiro EB, et al. Prevalence of people at risk of developing type 2 diabetes mellitus and the involvement of community pharmacies in a national screening campaign: a pioneer action in Brazil. Diabetol Metab Syndr. 2020;12:89. doi: 10.1186/s13098-020-00593-5. DOI: https://doi.org/10.1186/s13098-020-00593-5

Trefflich I, Jahn C, Jannasch F. Application of diabetes risk scores in health checkups. A comparison of the German Diabetes Risk Score (GDRS) and FINDRISK test. Ernahrungs Umsch. 2018;(65(11)):180-186. doi: 10.4455/eu.2018.041.

Aschner P. New IDF clinical practice recommendations for managing type 2 diabetes in primary care. Diabetes Res Clin Pract. 2017;132:169-170. doi: 10.1016/j.diabres.2017.09.002. DOI: https://doi.org/10.1016/j.diabres.2017.09.002

Saaristo T, Peltonen M, Lindström J, Saarikoski L, Sundvall J, Eriksson JG, et al. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res. 2005;2(2):67-72. doi: 10.3132/dvdr.2005.011. DOI: https://doi.org/10.3132/dvdr.2005.011

Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P. Cardiovascular risk factor changes in Finland, 1972-1997. Int J Epidemiol. 2000;29(1):49-56. doi: 10.1093/ije/29.1.49. DOI: https://doi.org/10.1093/ije/29.1.49

Michael O, Rotimi O, Sandra I. The performance of the Finnish Diabetes Risk Score (FINDRISC) questionaire for screening individuals with undiagnosed type 2 diabetes and dysglycaemia in Nigeria. Br J Med Med Res. 2017;19(5):1-8. doi: 10.9734/BJMMR/2017/31022. DOI: https://doi.org/10.9734/BJMMR/2017/31022

Pertiwi P, Perwitasari DA, Satibi S. Validation of Finnish Diabetes Risk Score Indonesia version in Yogyakarta. Borneo J Pharm. 2021;4(1):57-67. doi: 10.33084/bjop.v4i1.1575. DOI: https://doi.org/10.33084/bjop.v4i1.1575

Ayorinde AA, Porteous T, Sharma P. Screening for major diseases in community pharmacies: A systematic review. Int J Pharm Pract. 2013;21(6):349-361. doi: 10.1111/ijpp.12041. DOI: https://doi.org/10.1111/ijpp.12041

Fonseca A, Tacio Lima, Castelo-Branco M, Figueiredo IV. Feasibility of cardiovascular risk screening in Portuguese community pharmacies. Pharm Pract. 2021;19(2):2255. doi: 10.18549/PharmPract.2021.2.2255. DOI: https://doi.org/10.18549/PharmPract.2021.2.2255

Milovanovic S, Silenzi A, Kheiraoui F, Ventriglia G, Boccia S, Poscia A. Detecting persons at risk for diabetes mellitus type 2 using FINDRISC: results from a community pharmacy-based study. Eur J Public Health. 2018;28(6):1127-1132. doi: 10.1093/eurpub/cky009. DOI: https://doi.org/10.1093/eurpub/cky009

Gnavi R, Sciannameo V, Baratta F, Scarinzi C, Parente M, Mana M, et al. Opportunistic screening for type 2 diabetes in community pharmacies. Results from a region-wide experience in Italy. PLoS One. 2020;15(3):e0229842. doi: 10.1371/journal.pone.0229842. DOI: https://doi.org/10.1371/journal.pone.0229842

Fadheel QJ. Prevalence of diabetes mellitus and it’s complications in Iraq. Int J Pharm Qual Assur. 2018;9(2). doi: 10.25258/ijpqa.v9i2.13631. DOI: https://doi.org/10.25258/ijpqa.v9i2.13631

Hamasalih K, Nitham W. Nature and extent of counseling practice in community pharmacies in Sulaimani city, Iraq: A cross-sectional study. Zanco J Med Sci. 2021;25(3):686-691. doi: 10.15218/zjms.2021.035. DOI: https://doi.org/10.15218/zjms.2021.035

Cochran WG, Cochran WG, (Eds.), Sampling Techniques, (3rd edn.), Wiley; 1977.

National Diabetes Information Clearinghouse (NDIC). Blood glucose level. In: Definitions. Qeios; 2020. doi: 10.32388/AXOOVW. DOI: https://doi.org/10.32388/AXOOVW

Ogurtsova K, Guariguata L, Barengo NC, Ruiz PL, Sacre JW, Karuranga S, et al. IDF diabetes atlas: Global estimates of undiagnosed diabetes in adults for 2021. Diabetes Res Clin Pract. 2022;183:109118. doi: 10.1016/j.diabres.2021.109118. DOI: https://doi.org/10.1016/j.diabres.2021.109118

Velychko VI, Yurchenko IV, Lahoda DO, Yurchenko YeI. Type 2 diabetes mellitus: Epidemiology, complications and early diagnosis. Odessa Med J. 2023;(3):76-83. doi: 10.32782/2226-2008-2023-3-14. DOI: https://doi.org/10.32782/2226-2008-2023-3-14

Silvestre MP, Jiang Y, Volkova K, Chisholm H, Lee W, Poppitt SD. Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort. Prim Care Diabetes. 2017;11(6):561-569. doi: 10.1016/j.pcd.2017.07.003. DOI: https://doi.org/10.1016/j.pcd.2017.07.003

Meijnikman AS, De Block CEM, Verrijken A, Mertens I, Corthouts B, Van Gaal LF. Screening for type 2 diabetes mellitus in overweight and obese subjects made easy by the FINDRISC score. J Diabetes Complications. 2016;30(6):1043-1049. doi: 10.1016/j.jdiacomp.2016.05.004. DOI: https://doi.org/10.1016/j.jdiacomp.2016.05.004

Malindisa EK, Balandya E, Mashili F, Njelekela M. Is the FINDRISC tool useful in screening type 2 diabetes and metabolic syndrome in an African setting? Experience among young adults in Urban Tanzania. Diabetology. 2021;2(4):240-249. doi: 10.3390/diabetology2040022. DOI: https://doi.org/10.3390/diabetology2040022

Brewster S, Holt R, Portlock J, Price H. The role of community pharmacists and their position in the delivery of diabetes care: an update for medical professionals. Postgrad Med J. 2020;96(1138):473-479. doi: 10.1136/postgradmedj-2020-137511. DOI: https://doi.org/10.1136/postgradmedj-2020-137511

Twigg MJ, Poland F, Bhattacharya D, Desborough JA, Wright DJ. The current and future roles of community pharmacists: Views and experiences of patients with type 2 diabetes. Res Soc Adm Pharm. 2013;9(6):777-789. doi: 10.1016/j.sapharm.2012.10.004. DOI: https://doi.org/10.1016/j.sapharm.2012.10.004

La Regina R, Pandolfi D, Stabile N, Beloni L, Glisenti F, Griggio P, et al. A new case manager for diabetic patients: A pilot observational study of the role of community pharmacists and pharmacy services in the case management of diabetic patients. Pharmacy (Basel). 2020;8(4):193. doi: 10.3390/pharmacy8040193. DOI: https://doi.org/10.3390/pharmacy8040193

Arif R, Khan AZ, Hammad M, Ghani U, Vaddepalli R, Sanker V. Current practices and perceived role of community pharmacists in type 2 diabetes services in Pakistan. Cureus. 2023. doi: 10.7759/cureus.37311. DOI: https://doi.org/10.7759/cureus.37311

Atayoglu AT, Inanc N, Başmisirli E, Çapar AG. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) for diabetes screening in Kayseri, Turkey. Prim Care Diabetes. 2020;14(5):488-493. doi: 10.1016/j.pcd.2020.01.002. DOI: https://doi.org/10.1016/j.pcd.2020.01.002

González Villoria M, Jarque Fuertes MJ. Pilot trial on the detection of patients with undiagnosed diabetes mellitus type 2 performed in community pharmacies in Valladolid. Environmental impact evaluation. Farm Comunitarios. 2023;15(2):12-19. doi: 10.33620/FC.2173-9218.(2023).11. DOI: https://doi.org/10.33620/FC.2173-9218.(2023).11

Noor SKM, Farah MFA, Karar NAA, Bushara SOE, Sirelkhatim Ismaeil Sirri Farah SIS, Osman MSHM, et al. Benefit of Finnish score as a risk assessment tool for predicting type II DM among Sudanese population in North Sudan. Sudan J Med Sci. 2024;19(1):54–61. doi: 10.18502/sjms.v19i1.15766. DOI: https://doi.org/10.18502/sjms.v19i1.15766

Lindström J, Tuomilehto J. The diabetes risk score. Diabetes Care. 2003;26(3):725-731. doi: 10.2337/diacare.26.3.725. DOI: https://doi.org/10.2337/diacare.26.3.725

Fornos-Pérez JA, Andrés-Rodríguez NF, Andrés-Iglesias JC, Luna-Cano R, García-Soidán J, Lorenzo-Veiga B, et al. Detection of people at risk of diabetes in community pharmacies of Pontevedra (Spain) (DEDIPO). Endocrinol Nutr. 2016;63(8):387-396. doi: 10.1016/j.endonu.2016.06.002. DOI: https://doi.org/10.1016/j.endoen.2016.10.002

Agu U, Agu MC, Nnaji GA. Assessment of risk of developing diabetes mellitus among local government employees in Onitsha, south-eastern Nigeria. Epidemiol Rep. 2015;3(1):4. doi: 10.7243/2054-9911-3-4. DOI: https://doi.org/10.7243/2054-9911-3-4

Nnamudi AC, Orhue NEJ, Ijeh II. Assessment of the FINDRISC tool in predicting the risk of developing type 2 diabetes mellitus in a young adult Nigerian population. Bull Natl Res Cent. 2020;44(1):186. doi: 10.1186/s42269-020-00440-7. DOI: https://doi.org/10.1186/s42269-020-00440-7

Peters SAE, Bots SH, Woodward M. Sex differences in the association between measures of general and central adiposity and the risk of myocardial infarction: Results from the UK biobank. J Am Heart Assoc. 2018;7(5):e008507. doi: 10.1161/JAHA.117.008507. DOI: https://doi.org/10.1161/JAHA.117.008507

Elshebiny A, Alrashed A, Albuwaydi Z, Aljassim S, Alhammad F, Alhajji R. An assessment of the 10-year risk of developing type 2 diabetes among Saudi adults based on the Finnish Diabetes Risk Score. Cureus. 2022;14(11):e32034. doi: 10.7759/cureus.32034. DOI: https://doi.org/10.7759/cureus.32034

Bansal N. Prediabetes diagnosis and treatment: A review. World J Diabetes. 2015;6(2):296. doi: 10.4239/wjd.v6.i2.296. DOI: https://doi.org/10.4239/wjd.v6.i2.296